首页 | 本学科首页   官方微博 | 高级检索  
检索        

吡柔比星(THP)膀胱灌注预防膀胱癌术后复发的疗效观察
引用本文:肖振东,李长岭,许秉责.吡柔比星(THP)膀胱灌注预防膀胱癌术后复发的疗效观察[J].中国肿瘤临床,2000,27(2):158-160.
作者姓名:肖振东  李长岭  许秉责
作者单位:中国医学科学院中国协和医科大学肿瘤研究所肿瘤医院泌尿外科,北京市,100021
摘    要:目的;分析1998年6月-1999年8月间22例浅表性膀胱癌患者行膀胱部分切除术或行TUR-Bt及电灼术后采用吡柔比星膀胱灌注预防肿瘤复发。方法:THP30mg,每周一次,连用8周,而后每月1次,连用8个月。结果:总疗程10个月,平均随访9.7个月,复发率13.6%。结论:THP用于临床,效果好,不良反应少,给药方便,值得临床推广应用。

关 键 词:膀胱肿瘤  吡柔比星  膀胱灌注  复发

Clinical Study on Intravesical Instillation of Pirarubicin (CHP) for Prevention of Postoperative Recurrence of Bladder Cancer
Xiao Zhendong,Li Changling,Xu Bingze.Clinical Study on Intravesical Instillation of Pirarubicin (CHP) for Prevention of Postoperative Recurrence of Bladder Cancer[J].Chinese Journal of Clinical Oncology,2000,27(2):158-160.
Authors:Xiao Zhendong  Li Changling  Xu Bingze
Abstract:Objective:To study the effects of intravesical instillation of pirarubicin (THP) to prevent postoperative recurrence of superficial bladder cancer after partial cystectomy or transurethral resection (TUR-Bt) Methods: Intravesical instillation of 30mg of THP dissolved in 50ml normal saline and retained in bladder for 30 minutes was given to the patients once a week for 8 weeks and subsequently once a month for 8 months Results: The mean follow up time was 9 37 months and the tumor recurrence rate was 13 6% Conclusion: Intravesical instillation of THP is effective for prevention of postoperative recurrence of superficial bladder cancer with less side effect and easy to use so it can be widely used in such patients
Keywords:Bladder cancer  Intravesical instillation  Pirarubicin
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号